Search Tag: Frost & Sullivan
2014 02 Jun
The steady growth of the next-generation sequencing (NGS) market in Western Europe is expected to continue thanks to a variety of new applications, from comprehensive oncology panels to non-invasive prenatal analysis to food testing. Major market potential exists in areas such as pre-implantation genetic diagnosis, infectious disease and companion diagnostics,...Read more
2014 03 Apr
A new concept of ‘frugal innovation’ will be crucial to address the market challenges of the next few years Frost & Sullivan's annual congress ‘GIL 2014: Europe’, will examine new emerging trends in the Healthcare industry with a specific focus on the decisive market drivers over the coming years, both in Europe and beyond. Held in London for...Read more